Sanofi, GSK: COVID-19 Vaccine Candidate Selected By U.S. Government’s Operation Warp Speed

(RTTNews) - GlaxoSmithKline plc (GSK.L, GSK) and Sanofi (SNYNF, SNY) announced they were selected by U.S. government's Operation Warp Speed to supply with 100 million doses of COVID-19 recombinant protein-based vaccine. The U.S. government will provide up to $2.1 billion for development including clinical trials, manufacturing, scale-up and... To keep reading about Sanofi, GSK: COVID-19 Vaccine Candidate Selected By U.S. Government’s Operation Warp Speed, Click on the link. Seoul, Korea
http://dlvr.it/Rcl8CB

Comments

Popular posts from this blog

AstraZeneca Begins Phase I Trial Of AZD7442 Against COVID-19 – Quick Facts

AT&T Sells DirecTV Stake To Private Equity Firm TPG

7 lies to stop telling yourself if you want to become mentally stronger